Bayer-Backed Drug Maker Boundless Bio Raises $100 Million in IPO [BNN Bloomberg (Canada)]
Goldman Sachs Group, Inc. (The) (GS)
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
goldmansachs.com/investor-relations
Company Research
Source: BNN Bloomberg
The San Diego-based company sold 6.25 million shares on Wednesday for $16 each, according to a statement. The company had marketed the shares for $15 to $17, its filings with the US Securities and Exchange Commission show. At that price, Boundless Bio would have a market value of $356 million, based on the outstanding shares listed in its filings. Accounting for employee stock options and restricted stock units, the company would have a fully diluted value of $550 million. Founded in 2018 by ARCH Venture Partners, Boundless Bio is a clinical-stage oncology company whose therapies target extrachromosomal DNA, which causes certain types of cancers. The company raised $100 million last May in a series C round co-led by Leaps by Bayer and RA Capital Management, according to a statement. ARCH will continue to have an 11.2% stake in Boundless Bio after the offering, the filings show. FMR LLC will control 10.6% of the shares, RA Capital will have 8.4% and Bayer will beneficially own 6
Show less
Read more
Impact Snapshot
Event Time:
GS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GS alerts
High impacting Goldman Sachs Group, Inc. (The) news events
Weekly update
A roundup of the hottest topics
GS
News
- Billionaire Miami Dolphins owner wants to make South Florida more like Manhattan—'I still love a challenge' [Fortune]Fortune
- Inside the life of a sports banker: Top dealmakers from Goldman Sachs, PJT, Raine, and more break down the job. [Business Insider]Business Insider
- 15 Best States to Retire in The US Financially [Yahoo! Finance]Yahoo! Finance
- 10 Best Technology Dividend Aristocrats to Buy [Yahoo! Finance]Yahoo! Finance
- Galvanize Real Estate Acquires First Asset in Pioneering Profitable Decarbonization Strategy [Yahoo! Finance]Yahoo! Finance
GS
Earnings
- 4/15/24 - Beat
GS
Sec Filings
- 4/26/24 - Form 424B2
- 4/26/24 - Form 424B2
- 4/26/24 - Form 485BPOS
- GS's page on the SEC website